Home > Analytics > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524412     NSE : AAREYDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Apr 16,2025
Price(EOD): ₹ 55.53
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 157.71 Cr
Value of ₹ 1 Lac invested in AAREY DRUGS & PHARMACEUTICALS
on Apr 16,2020 (price: ₹ 22.49)

₹ 1 L

₹ 2.47 L

1W : 18.9% 1M : 47.8% 1Y : 9.8%
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS 18.9% 47.8% 9.8%
SUN PHARMACEUTICAL INDUSTRIES 0.2% 1% 6.3%
DIVIS LABORATORIES 6.8% 1.6% 53.3%
CIPLA 4.4% 2.9% 4.1%
TORRENT PHARMACEUTICALS -0.7% 4% 25.1%
DR REDDYS LABORATORIES 4.6% 4.9% -6.2%
MANKIND PHARMA 7.6% 16.3% 2.5%
ZYDUS LIFESCIENCES -4.4% -7.5% -11.1%
LUPIN -2.4% -1.5% 25.3%

FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Dec2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF AAREY DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Apr 16,2025 ]

Ratio Standalone
P/E
P/B
P/S
27.61
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 5.70 Cr
[Latest Qtr - Dec2024 - Standalone Results ]

1.21
P/B Calculated based on Book Value of Rs 130.31 Cr
[Latest Year - Mar2024 - Standalone Results ]

0.27
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 21% undervalued companies ! Discover More →

FAIR VALUE OF AAREY DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
1361%
-11%
-7%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS


Insights 💡 AAREYDRUGS is one of the top 46% companies with bullish price momentum currently! Discover More →

AAREY DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AAREY DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.24
0.33
0.13
0.23
-
-
-
-
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Dec2024

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
27.24%
-40.89%
-19.82%
-55.01%
74.94%
-18.5%
-4.37%
-29.68%
QtrlyTrend
-4
Latest Qtr: Dec2024
Quarterly Result Analysis →


AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS


Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?

As on Apr 16,2025, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Apr 16,2025, AAREY DRUGS & PHARMACEUTICALS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?

As on Apr 16,2025, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 59.57 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 3.80
Fair Value [Median EV / Sales Model] : Rs. 62.41
Fair Value [Median Price / Sales Model] : Rs. 59.57
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 59.57

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AAREY DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Apr 16,2025, AAREY DRUGS & PHARMACEUTICALS is trading at a Discount of -7% based on the estimates of Median Intrinsic Value!